Differential protective effects of Bcl-X(L) and Bcl-2 on apoptotic liver injury in transgenic mice

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 277, Issue 3 40-3, 1999, Pages

  De la Coste, Alix ^a   Fabre, Monique ^b   McDonell, Nathalie ^a   Porteu, Arlette ^a   Gilgenkrantz, Helène ^a   Perret, Christine ^a   Kahn, Axel ^a   Mignon, Alexandre ^a  

^a INSERM   (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

Apoptosis; Fas CD95; Tumor necrosis factor

Indexed keywords

CASPASE 3; FAS LIGAND; PROTEIN BCL 2; PROTEIN BCL X; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEPATITIS; LIVER CELL; LIVER INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0032861255     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1999.277.3.g702     Document Type: Article

References (37)

1. Adams, J. M., and S. Cory. The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326, 1998.
2. Arsura, M., M. J. FitzGerald, N. Fausto, and G. E. Sonenshein. Nuclear factor-κB/Rel blocks transforming growth factor β1-induced apoptosis of murine hepatocyte cell lines. Cell Growth Differ. 8: 1049-1059, 1997.
3. Ashkenazi, A., and V. M. Dixit. Death receptors: signaling and modulation. Science 281: 1305-1308, 1998.
4. Baichwal, V. R., and P. A. Baeuerle. Activate NF-kappa B or die? Curr. Biol. 7: 94-96, 1997.
5. Beg, A. A., and D. Baltimore. An essential role for NF-kappa B in preventing TNF-α-induced cell death. Science 274: 782-784, 1996.
6. Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376: 167-170, 1995.
7. Bellas, R. E., M. J. FitzGerald, N. Fausto, and G. E. Sonenshein. Inhibition of NF-kappa B activity induces apoptosis in murine hepatocytes. Am. J. Pathol. 151: 891-896, 1997.
8. Boise, L. H., M. Gonzalez-Garcia, C. E. Postema, L. Ding, T. Lindsten, L. A. Turka, X. Mao, G. Nunez, and C. B. Thompson. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608, 1993.
9. Boise, L. H., and C. B. Thompson. Bcl-x(L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc. Natl. Acad. Sci. USA 94: 3759-3764, 1997.
10. Cereghini, S., M. Raymondjean, A. G. Carranca, P. Herbomel, and M. Yaniv. Factors involved in control of tissue-specific expression of albumin gene. Cell 50: 627-638, 1987.
11. Cheng, E. H., D. G. Kirsch, R. J. Clem, R. Ravi, M. B. Kastan, A. Bedi, K. Ueno, and J. M. Hardwick. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278: 1966-1968, 1997.
12. Cheng, E. H., B. Levine, L. H. Boise, C. B. Thompson, and J. M. Hardwick. Bax-independent inhibition of apoptosis by Bel-XL. Nature 379: 554-556, 1996.
13. Chinnaiyan, A. M., K. Orth, K. O'Rourke, H. Duan, G. G. Poirier, and V. M. Dixit. Molecular ordering of the cell death pathway. Bcl-2 and Bcl-xL function upstream of the CED-3-like apoptotic proteases. J. Biol. Chem. 271: 4573-4576, 1996.
14. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299, 1979.
15. Clem, R. J., E. H. Cheng, C. L. Karp, D. G. Kirsch, K. Ueno, A. Takahashi, M. B. Kastan, D. E. Griffin, W. C. Earnshaw, M. A. Veliuona, and J. M. Hardwick. Modulation of cell death by Bcl-XL through caspase interaction. Proc. Natl. Acad. Sci. USA 95: 554-559, 1998.
16. Faubion, W. A., and G. J. Gores. Death receptors in liver biology and pathobiology. Hepatology 29: 1-4, 1999.
17. Gonzalez-Garcia, M., R. Perez-Ballestero, L. Ding, L. Duan, L. H. Boise, C. B. Thompson, and G. Nunez. Bcl-XL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. Development 120: 3033-3042, 1994.
18. Green, D. R., and J. C. Reed. Mitochondria and apoptosis. Science 281: 1309-1312, 1998.
19. Hockenbery, D. M., M. Zutter, W. Hickey, M. Nahm, and S. J. Korsmeyer. Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA 88: 6961-6965, 1991.
20. Iimuro, Y., T. Nishiura, C. Hellerbrand, K. E. Behrns, R. Schoonhoven, J. W. Grisham, and D. A. Brenner. NFκB prevents apoptosis and liver dysfunction during liver regeneration. J. Clin. Invest. 101: 802-811, 1998.
21. Kosai, K., K. Matsumoto, S. Nagata, Y. Tsujimoto, and T. Nakamura. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. Biochem. Biophys. Res. Commun. 244: 683-690, 1998.
22. Lacronique, V., A. Mignon, M. Fabre, B. Viollet, N. Rouquet, T. Molina, A. Porteu, A. Henrion, D. Bouscary, P. Varlet, V. Joulin, and A. Kahn. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat. Med. 2: 80-86, 1996.
23. Leist, M., F. Gantner, I. Bohlinger, P. G. Germann, G. Tiegs, and A. Wendel. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest. J. Immunol. 153: 1778-1788, 1994.
24. Leist, M., F. Gantner, I. Bohlinger, G. Tiegs, P. G. Germann, and A. Wendel. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am. J. Pathol. 146: 1220-1234, 1995.
25. Li, Q., D. van Antwerp, F. Mercurio, K. F. Lee, and I. M. Verma. Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science 284: 321-325, 1999.
26. Michalopoulos, G. K., and M. C. De Frances. Liver regeneration. Science 276: 60-66, 1997.
27. Ogasawara, J., R. Watanabe-Fukunaga, M. Adashi, A. Matsuzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata. Lethal effect of the anti-Fas antibody in mice. Nature 364: 806-809, 1993.
28. Patel, T., and G. J. Gores. Apoptosis and hepatobiliary disease. Hepatology 21: 1725-1741, 1995.
29. Reed, J. C. Cytochrome c: can't live with it - can't live without it. Cell 91: 559-562, 1997.
30. Rodriguez, I., K. Matsuura, K. Khatib, J. C. Reed, S. Nagata, and P. Vassalli. A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection. J. Exp. Med. 183: 1031-1036, 1996.
31. Schlegel, J., I. Peters, S. Orrenius, D. K. Miller, N. A. Thornberry, T. T. Yamin, and D. W. Nicholson. CPP32/ apopain is a key interleukin 1 β converting enzyme-like protease involved in Fas-mediated apoptosis. J. Biol. Chem. 271: 1841-1844, 1996.
32. Shimizu, S., Y. Eguchi, W. Kamiike, Y. Funahashi, A. Mignon, V. Lacronique, H. Matsuda, and Y. Tsujimoto. Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux. Proc. Natl. Acad. Sci. USA 95: 1455-1459, 1998.
33. Takehara, T., N. Hayashi, E. Mita, T. Kanto, T. Tatsumi, Y. Sasaki, A. Kasahara, and M. Hori. Delayed Fas-mediated hepatocyte apoptosis during liver regeneration in mice: hepato-protective role of TNF α. Hepatology 27: 1643-1651, 1998.
34. Taub, R. Blocking NF-κB in the liver: the good and bad news. Hepatology 27: 1445-1446, 1998.
35. Thornberry, N. A., and Y. Lazebnik. Caspases: enemies within. Science 281: 1312-1316, 1998.
36. Vander Heiden, M. G., N. S. Chandel, E. K. Williamson, P. T. Schumacker, and C. B. Thompson. Bcl-xL regulates the membrane potential and volume homeostasis of. Cell 91: 627-637, 1997.
37. Zong, W. X., L. C. Edelstein, C. Chen, J. Bash, and C. Gelinas. The prosurvival bcl-2 homolog bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis. Genes Dev. 13: 382-387, 1999.